RT Conference Proceedings
T1 Effect of diarrheal prophylaxis or dose escalation on neratinib-associated diarrhea and tolerability in patients with HER2+early-stage breast cancer: Final findings from the CONTROL trial
A1 Chan, A.
A1 Ruiz Borrego, M.
A1 Marx, G.
A1 Brufsky, A.
A1 Chien, A. J.
A1 Thirlwell, M. P.
A1 Trudeau, M. E.
A1 Bose, R.
A1 Saenz, J. A. Garcia
A1 Egle, D.
A1 Pistilli, B.
A1 Wassermann, J.
A1 Cheong, K. A.
A1 Semsek, D.
A1 Singer, C. F.
A1 Diprimeo, D.
A1 Foruzan, N.
A1 McCulloch, L. M.
A1 Barcenas, C. H.
PB Elsevier
SN 0923-7534
YR 2022
FD 2022-05-05
LK http://hdl.handle.net/10668/21900
UL http://hdl.handle.net/10668/21900
LA en
DS RISalud
RD Apr 9, 2025